Prostate cancer treatment with pembrolizumab and olaparib yields promising outcomes: Study Dr. Kamal Kant Kohli12 Oct 2022 7:30 PM ISTUSA: According to a research published in the European Urology journal, pembrolizumab plus olaparib exhibited an antitumor effect and predicted...
Phase II trial of Jemperli (dostarlimab) plus chemotherapy in patients with metastatic non-squamous non-small cell lung cancer shows positive headline results: GSK Ruchika Sharma9 Oct 2022 2:00 PM ISTJemperli is a programmed death receptor-1 (PD-1)-blocking antibody that binds to the PD-1 receptor and blocks its interaction with the PD-1 ligands...
Preoperative Pembrolizumab may not increase complications during or after oral cavity cancer surgery Dr. Kamal Kant Kohli8 Sept 2022 4:00 PM ISTPembrolizumab is sold under the brand name Keytruda and is an antibody used in cancer immunotherapy that treats a variety of cancers, including cancer...
Merck Keytruda fails head and neck cancer trial Rahul Verma21 July 2022 5:00 PM ISTMerck, known as MSD outside the United States and Canada, has announced that the Phase 3 KEYNOTE-412 trial evaluating KEYTRUDA (pembrolizumab),...
Merck Keytruda fails in head and neck cancer trial Ruchika Sharma21 July 2022 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Aurobindo Pharma arm bags USFDA nod for Pemetrexed for Injection Ruchika Sharma26 May 2022 1:14 PM ISTPemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
Merck to stop Phase 3 KEYLYNK-010 trial investigating Combo therapy of KEYTRUDA and LYNPARZA MD Bureau18 March 2022 2:00 PM ISTMerck, known as MSD outside the United States and Canada, today announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA,...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima Ruchika Sharma30 Dec 2021 12:22 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
Merck gets USFDA approval for adjuvant Keytruda for pediatric, adult Melanoma Ruchika Sharma5 Dec 2021 9:30 AM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (USFDA) has approved...
Merck Keytruda gets USFDA nod as adjuvant kidney cancer treatment Ruchika Sharma19 Nov 2021 3:56 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, has recently announced that the U.S. Food and Drug Administration (FDA)...
Gilead Sciences, Merck collaborate to evaluate Trodelvy in combo with Keytruda Ruchika Sharma31 Oct 2021 9:30 AM ISTFoster City: Gilead Sciences, Inc. has recently announced the company has entered into a clinical trial collaboration and supply agreement with Merck...
Pembrolizumab increases survival of patients with unresectable cervical cancer on chemotherapy: NEJM MD Editorial Team30 Sept 2021 9:00 AM ISTPembrolizumab is a highly selective humanized monoclonal IgG4 antibody directed against the PD1 receptor on the cell surface. A new study by Dr...
